CIK 0001042418 · Non-accelerated filer<br>Smaller reporting company
Inhibitor Therapeutics, Inc.
Sign in to watch- Ticker
- INTI
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 541641133
- Phone
- (813) 766-2462
- Business address
- 4830 W. KENNEDY BLVD., SUITE 600, TAMPA, FL, 33609
- Former names
- HedgePath Pharmaceuticals, Inc., COMMONWEALTH BIOTECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 78 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-24 | ODONNELL FRANCIS E JR Executive Chairman | Other acquisition · Warrant to purchase Common Stock | +2,716,401 | 2,716,401 | ||
| 2014-06-24 | ODONNELL FRANCIS E JR Executive Chairman | Other acquisition · Series A Convertible Preferred Stock | +4,011.62 | 13,531.66 | ||
| 2014-06-24 | ODONNELL FRANCIS E JR Executive Chairman | Other acquisition · Series A Convertible Preferred Stock | +18,983.54 | 64,033.73 | ||
| 2014-06-24 | Mayne Pharma Ventures Pty Ltd Director | Grant or award · Series A Convertible Preferred Stock | +258,363.28 | 258,363.28 | ||
| 2014-06-24 | Mayne Pharma Ventures Pty Ltd Director | Grant or award · Common Stock Purchase Warrant | +1 | 1 | ||
| 2013-08-13 | ODONNELL FRANCIS E JR Executive Chairman | Grant or award · Series A Convertible Preferred Stock | +9,520.04 | 9,520.04 | ||
| 2013-08-13 | ODONNELL FRANCIS E JR Executive Chairman | Grant or award · Series A Convertible Preferred Stock | +45,050.2 | 45,050.2 | ||
| 2013-08-13 | HedgePath, LLC Director | Grant or award · Series A Convertible Preferred Stock | +170,000.74 | 170,000.74 | ||
| 2013-04-12 | FREER RICHARD J Chief Executive Officer | Other acquisition | +2,846,715 | $0.05 | $130K | 7,485,141 |
| 2013-04-12 | SEARS SAMUEL P JR Director | Other acquisition | +372,263 | $0.05 | $17K | 1,016,096 |
| 2012-08-22 | FREER RICHARD J Chief Executive Officer | Other acquisition | +2,025,000 | $0.02 | $41K | 4,638,426 |
| 2010-01-19 | D'Sylva Paul Director | Sale | −19,100 | $0.50 | $10K | 271,216 |
| 2009-05-29 | D'Sylva Paul Director | Purchase | +12,000 | $0.40 | $5K | 290,316 |
| 2009-05-15 | D'Sylva Paul Director | Purchase | +510 | $0.38 | $194 | 278,316 |
| 2009-05-14 | D'Sylva Paul Director | Purchase | +2,800 | $0.40 | $1K | 277,806 |
| 2009-05-05 | D'Sylva Paul Director | Purchase | +23,934 | $0.35 | $8K | 275,006 |
| 2009-05-04 | D'Sylva Paul Director | Purchase | +500 | $0.35 | $175 | 251,072 |
| 2009-05-01 | D'Sylva Paul Director | Purchase | +5,866 | $0.35 | $2K | 250,572 |
| 2009-04-30 | D'Sylva Paul Director | Purchase | +19,706 | $0.35 | $7K | 244,706 |
| 2008-12-29 | REYNOLDS THOMAS R Executive VP | Grant or award | +25,000 | 50,719 |
Page 8 of 9 · 165 trades